Oversea-Chinese Banking Corp Ltd-Outlook stable along with lower allowances

8 Nov 2021
  • 3Q21 earnings PATMI of S$1.22bn in line with our estimate. 9M21 PATMI is 80% of our FY21e forecast on lower-than-expected allowances.
  • NIM fell 6bps QoQ, though NII remained flat in the same period and grew 3% YoY.
  • Provisions were 53% YoY lower to S$163mn due to lower SPs and GP write-back. Asset quality suffered due to an increase in loans under relief in Malaysia.
  • Maintain BUY with an unchanged target price of S$14.22. We raise FY21e earnings by 1.8% as we increase profits of associates. Our TP remains unchanged at 1.24x P/BV and 9.3% FY21e ROE. Catalyst includes lower provisions and higher interest income as economic conditions improve.

The Positives

+ Fee income grew 14% YoY. Fee and commission income grew 14% YoY and 1% QoQ, particularly from wealth management income which made up 35% (S$897mn) of the Group’s income in 3Q21. The Group’s assets under management (AUM) fell to S$123bn, matching 1Q21, mainly due to the decline in market valuations which offset net new money inflows.

+ GP write-backs of S$22mn. OCBC was able to write back GPs of S$22mn during the quarter as the credit environment improved while SPs of S$185mn were made. Total NPAs rose by 4% QoQ to S$4.2bn, mostly attributed to downgrades of secured consumer loans in Malaysia. Nonetheless, OCBC has set aside S$185mn of SPs this quarter mainly for corporate and consumer accounts in Malaysia and Indonesia. Group NPLs were stable at 1.5% in 2Q21.

The Negatives

– NIM fell 6bps QoQ to 1.52%. NIM declined by 6bps QoQ mainly due to the classification of loans to NPL (mostly from downgrades of secured consumer loans in Malaysia) and more competitive corporate loans which resulted in lower asset yields.  As such, management expects NIM to maintain at 1.5%-1.52% until 1H22. Nonetheless, NII grew 3% YoY and remained flat QoQ, underpinned by loans growth of 4% QoQ and 6% YoY, backed by demand from Greater China, Singapore and the United Kingdom. Loan growth this quarter was led by higher loans to the building and construction sector.

– Loans under moratorium unchanged at 2%. Loans under moratorium remained at 2% of the total, unchanged from the last quarter. The portfolio of relief loans, however, increased to S$6.3bn in 3Q21 from S$4.5bn. The increase was due to an increase in Malaysia’s relief loans to S$4bn in 3Q21 from $1.5bn, representing 19% of Malaysia’s total loans. Nonetheless, management has mentioned that the majority of loans under moratorium are performing loans, with all loans under moratorium in Singapore performing and about 20% of Malaysia’s loans under moratorium non-performing. Management expects the non-performing loans under moratorium to drop with the improving economic situation. 89% of all loans under moratorium remain secured.

Outlook

Loan growth: Loans grew 6% YoY in 3Q21, trailing the bank’s guidance of a high single-digit increase for FY21e. Management, however, believes its target is achievable. It sees lending opportunities in the wholesale segment and sustainable financing. Green and sustainable finance was up 12% QoQ to S$19.5bn and now forms 7% of its loan book. Mortgage pipelines in Singapore and Hong Kong are also healthy, with drawdowns expected in 2H21.

China: OCBC’s total exposure to mainland China remains at 11% of Group loans, with onshore exposure at S$6bn and offshore exposure at S$26bn. Nonetheless, customers include mainly top state-owned enterprises, large local corporates, as well as OCBC’s network customers. Less than one-third of the Group’s Mainland China onshore exposure (S$2bn) are corporate real estate loans, largely lending to the bank’s network customer. NPL ratio for non-bank Mainland China loans dipped to 0.3% from 0.5% in the previous quarter.

NPL: Non-performing assets rose 4% QoQ, due to new NPA formation of S$804mn mainly from the downgrades of secured consumer loans in Malaysia offset by recoveries and upgrades of S$359mn mainly from several corporate accounts in the oil and gas support vessels and services sector. We expect loans under relief to nudge higher as the COVID situation recovers gradually in Malaysia and Indonesia. In anticipation of this, management set aside S$185mn of SPs this quarter mainly for corporate and consumer accounts in Malaysia and Indonesia.

Investment Action

Maintain BUY with an unchanged target price of S$14.22

We maintain our BUY recommendation with an unchanged GGM target price of S$14.22. We raise FY21e earnings by 1.8% as we increase profits of associates. Our TP remains unchanged at 1.24x P/BV and 9.3% FY21e ROE. Catalyst includes lower provisions and higher interest income as economic conditions improve.

About the author

Glenn Thum
Research Analyst
PSR

Glenn covers the Banking and Finance sector. He has had 3 years of experience as a Credit Analyst in a Bank, where he prepared credit proposals by conducting consistent critical analysis on the business, market, country and financial information. Glenn graduated with a Bachelor of Business Management from the University of Queensland with a double major in International Business and Human Resources.

Latest Reports

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com